Back to today’s briefing

Story perspectives

New Gene Score Predicts Colon Cancer Patient Outcomes

9/18/2025

40 7

Summary

Story summary

Researchers developed a composite risk score using CD274 (PD-L1), PTGS2 (COX-2), and CD8A expression to evaluate patient prognosis.
Patients were categorized into high- and low-risk groups based on median values.
Gene set enrichment analysis (GSEA) compared PTGS2 expression in colon cancer samples.
The study followed patients from diagnosis until August 31, 2016.
Ethical approval was granted by Lund University, Sweden.

1 of 1

Story summary

Researchers developed a composite risk score using CD274 (PD-L1), PTGS2 (COX-2), and CD8A expression to evaluate patient prognosis.
Patients were categorized into high- and low-risk groups based on median values.
Gene set enrichment analysis (GSEA) compared PTGS2 expression in colon cancer samples.
The study followed patients from diagnosis until August 31, 2016.
Ethical approval was granted by Lund University, Sweden.